Factors influencing economic toxicity and coping strategies in lung cancer patients: A scoping review.

OBJECTIVE

A scoping review aims to identify the factors that contribute to economic challenges for lung cancer patients, as well as effective responses to these challenges. This review will help in identifying lung cancer patients at risk of financial difficulties, shaping health policies, and allocating healthcare resources effectively.

DATA SOURCES

This review includes both published and unpublished empirical studies.

METHODS

Following the scoping review guidelines set forth by the Joanna Briggs Institute (JBI), we conducted searches in databases including Pubmed, Embase, OVID, Sinomed, Web of Science, Proquest, Wanfang, and CNKI from the establishment of the repository to February 2024. We organized and analyzed the included literature.

FINDINGS

16 papers were included in the review. We extracted assessment tools, influencing factors, and responses to economic challenges faced by lung cancer patients from the included literature. The main assessment tools for economic challenges include COST, questionnaires, medical records, burden calculations, and other relevant tools. Factors influencing economic challenges in lung cancer patients mainly include age, occupation, insurance, education, treatment, disease duration, and income. Coping strategies for economic challenges in lung cancer patients primarily include institutional, technological, and managerial reforms, as well as public education and psychological interventions.

CONCLUSION

The prevalence of economic challenges faced by lung cancer patients is influenced by several complex factors. Healthcare professionals can develop screening tools and intervention protocols based on these influencing factors, providing a foundation for implementing targeted intervention programs for lung cancer patients at high risk of economic challenges.